Amgen (AMGN) Up About 1% as Rally Continues after UK Acceptance
Posted on June 15, 2012 at 09:59 AM EDT
Amgen (NASDAQ: AMGN) rose again Friday, continuing a trend that began earlier in the week when a U.K. regulatory body approved the company's drug denosumab for breast cancer patients whose cancer has spread t...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)